[HTML][HTML] A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials

L Sforzini, C Worrell, M Kose, IM Anderson… - Molecular …, 2022 - nature.com
Criteria for treatment-resistant depression (TRD) and partially responsive depression (PRD)
as subtypes of major depressive disorder (MDD) are not unequivocally defined. In the …

Fluoxetine versus other types of pharmacotherapy for depression

LR Magni, M Purgato, C Gastaldon… - Cochrane Database …, 2013 - cochranelibrary.com
Background Depression is common in primary care and is associated with marked personal,
social and economic morbidity, thus creating significant demands on service providers. The …

Minimal clinically important difference on the Beck Depression Inventory-II according to the patient's perspective

KS Button, D Kounali, L Thomas, NJ Wiles… - Psychological …, 2015 - cambridge.org
BackgroundThe Beck Depression Inventory, 2nd edition (BDI-II) is widely used in research
on depression. However, the minimal clinically important difference (MCID) is unknown …

Exercise and severe major depression: effect on symptom severity and quality of life at discharge in an inpatient cohort

FB Schuch, MP Vasconcelos-Moreno… - Journal of psychiatric …, 2015 - Elsevier
Background Exercise is a potential treatment for depression. However, few studies have
evaluated the role of adjunct exercise in the treatment of severely major depressed …

Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how

WE Craighead, BW Dunlop - Annual review of psychology, 2014 - annualreviews.org
Major depressive disorder (MDD) is among the most frequent and debilitating psychiatric
disorders. Efficacious psychotherapy and antidepressant medications have been …

Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder

BW Dunlop, ME Kelley, TC Mletzko… - Journal of psychiatric …, 2012 - Elsevier
Previous studies suggest that individual preferences for medication-or psychotherapy-based
treatments for depression may affect outcomes in clinical trials that compare these two forms …

Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR* D data

H Sakurai, T Suzuki, K Yoshimura, M Mimura… - …, 2017 - Springer
Background Residual symptoms are detrimental to prognosis in major depressive disorder
(MDD); however, little is known about the contribution of each residual symptom in …

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study

D Saragoussi, M Touya, JM Haro… - Neuropsychiatric …, 2017 - Taylor & Francis
Background The Prospective Epidemiological Research on Functioning Outcomes Related
to Major Depressive Disorder (PERFORM) study has been initiated to better understand the …

[HTML][HTML] Manual or electroacupuncture as an add-on therapy to SSRIs for depression: a randomized controlled trial

B Zhao, Z Li, Y Wang, X Ma, X Wang, X Wang… - Journal of psychiatric …, 2019 - Elsevier
Selective serotonin reuptake inhibitors (SSRIs) are first-line antidepressants, however, only
around 60% of patients could benefit from them. Acupuncture is supported by insufficient …

Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice?

M Zimmerman, E Walsh, M Friedman… - Journal of Affective …, 2018 - Elsevier
Objective Recent treatment guidelines have suggested that outcome should be measured in
routine clinical practice. In the present report from the Rhode Island Methods to Improve …